Rutgers Cancer Institute of New Jersey: $500K Grant Supports Exploration of Therapies for Difficult-to-Treat Lymphomas
January 03, 2024
January 03, 2024
NEW BRUNSWICK, New Jersey, Jan. 3 -- Rutgers Cancer Institute of New Jersey issued the following news:
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state's leading cancer program and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and associate professor of pharmacology and pediatrics at Rutgers Robert Wood Johnson Medical School, has received a $500,000 collaborative grant from Gabrielle's A . . .
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state's leading cancer program and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and associate professor of pharmacology and pediatrics at Rutgers Robert Wood Johnson Medical School, has received a $500,000 collaborative grant from Gabrielle's A . . .